BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Garbuzenko DV, Arefyev NO, Kazachkov EL. Antiangiogenic therapy for portal hypertension in liver cirrhosis: Current progress and perspectives. World J Gastroenterol 2018; 24(33): 3738-3748 [PMID: 30197479 DOI: 10.3748/wjg.v24.i33.3738]
URL: https://www.wjgnet.com/1948-5182/full/v24/i33/3738.htm
Number Citing Articles
1
Wolfgang Kreisel, Denise Schaffner, Adhara Lazaro, Jonel Trebicka, Irmgard Merfort, Annette Schmitt-Graeff, Peter Deibert. Phosphodiesterases in the Liver as Potential Therapeutic Targets of Cirrhotic Portal HypertensionInternational Journal of Molecular Sciences 2020; 21(17): 6223 doi: 10.3390/ijms21176223
2
Hui Li. Angiogenesis in the progression from liver fibrosis to cirrhosis and hepatocelluar carcinomaExpert Review of Gastroenterology & Hepatology 2021; 15(3): 217 doi: 10.1080/17474124.2021.1842732
3
Sheng-Hung Chen, Hsueh-Chou Lai, Wen-Pang Su, Jung-Ta Kao, Wei-Fan Hsu, Hung-Wei Wang, Hung-Yao Chen, Cheng-Yuan Peng. Liver stiffness and spleen stiffness predict distinct liver-related events after hepatitis C eradication with direct-acting antiviralsJournal of the Formosan Medical Association 2024;  doi: 10.1016/j.jfma.2024.02.016
4
Hong Zhou, Han Hu, Maoyong Tian, Jun Chu, Caiyun Tian, Yanqing Yang, Shide Lin, Chiara Ricci. Validation and Refinement of the Baveno VI Criteria for Ruling Out High-Risk VaricesGastroenterology Research and Practice 2020; 2020: 1 doi: 10.1155/2020/4217512
5
Sigita Gelman, Violeta Salteniene, Andrius Pranculis, Jurgita Skieceviciene, Romanas Zykus, Dalius Petrauskas, Limas Kupcinskas, Ali Canbay, Alexander Link, Juozas Kupcinskas. Plasma Nogo-A and placental growth factor levels are associated with portal hypertension in patients with liver cirrhosisWorld Journal of Gastroenterology 2019; 25(23): 2935-2946 doi: 10.3748/wjg.v25.i23.2935
6
N. R. Matkovska. MORTALITY ANALYSIS OF THE PATIENTS WITH ALCOHOLIC LIVER CIRRHOSISInternational Journal of Medicine and Medical Research 2019; 5(1): 40 doi: 10.11603/ijmmr.2413-6077.2019.1.9857
7
D. V. Garbuzenko. Current strategies for targeted therapy of liver fibrosisBulletin of Siberian Medicine 2022; 21(3): 154 doi: 10.20538/1682-0363-2022-3-154-165
8
Xinyuan Wang, Juan Li, Jiao Nong, Xin Deng, Yiping Chen, Peibin Wu, Xiabing Huang. Curcumol Attenuates Portal Hypertension and Collateral Shunting Via Inhibition of Extrahepatic Angiogenesis in Cirrhotic RatsBiochemical Genetics 2024;  doi: 10.1007/s10528-024-10684-x
9
Analysis of Causes of Death in Patients with Alcoholic Liver Cirrhosis Associated with Non-alcoholic Fatty Liver DiseaseFamily medicine 2019; (4): 47 doi: 10.30841/2307-5112.4.2019.184588
10
Dmitry Victorovich Garbuzenko, Nikolay Olegovich Arefyev. Primary prevention of bleeding from esophageal varices in patients with liver cirrhosis: An update and review of the literatureJournal of Evidence-Based Medicine 2020; 13(4): 313 doi: 10.1111/jebm.12407
11
Adhara Lazaro, Patrick Stoll, Dominik von Elverfeldt, Wolfgang Kreisel, Peter Deibert. Close Relationship between Systemic Arterial and Portal Venous Pressure in an Animal Model with Healthy LiverInternational Journal of Molecular Sciences 2023; 24(12): 9963 doi: 10.3390/ijms24129963
12
Xingyao Hu, Guangbin Shang, Jie Zhang, Zhong Chen, Liu Fu, Jun Li, Xiaonan Lu. Clinical Yi-guan decoction for liver cirrhosisMedicine 2021; 100(13): e24530 doi: 10.1097/MD.0000000000024530
13
Chalermrat Bunchorntavakul, K. Rajender Reddy. Pharmacologic Management of Portal HypertensionClinics in Liver Disease 2019; 23(4): 713 doi: 10.1016/j.cld.2019.06.004
14
Eun Jeoung Lee, Yun Kim, Ji Eun Kim, Eileen Laurel Yoon, Sung Ryol Lee, Dae Won Jun. ALS-L1023 from Melissa officinalis Alleviates Liver Fibrosis in a Non-Alcoholic Fatty Liver Disease ModelLife 2022; 13(1): 100 doi: 10.3390/life13010100
15
Yanting Ye, Chao Xia, Hong Hu, Shihang Tang, Hui Huan. Metabolomics reveals altered metabolites in cirrhotic patients with severe portal hypertension in Tibetan populationFrontiers in Medicine 2024; 11 doi: 10.3389/fmed.2024.1404442
16
M. L. Katsin, M. Y. Hurava, Pavel S. Prylutski, A. M. Dzyadz’ko, O. O. Rummo. Pathogenesis and clinical significance of the hyperdynamic circulatory syndrome in liver cirrhosis. ReviewAnnals of Critical Care 2021; (1): 123 doi: 10.21320/1818-474X-2021-1-123-133